Company record
UCB Biosciences Inc.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about UCB Biosciences Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 27 | Class II | UCB Biosciences Inc. Drug |
cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, … Lack of Assurance of Sterility |